| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Robert L Talbert | |
| Hayley Gray | |||
| Jennifer Seltzer | |||
| P2860 | cites work | Testosterone replacement therapy in patients with prostate cancer after radical prostatectomy | Q28285210 |
| Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels | Q28301408 | ||
| Eligibility and response guidelines for phase II clinical trials in androgen-independent prostate cancer: recommendations from the Prostate-Specific Antigen Working Group. | Q33767866 | ||
| Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference | Q34541651 | ||
| Testosterone and prostate cancer: an historical perspective on a modern myth | Q34552217 | ||
| Risks of testosterone-replacement therapy and recommendations for monitoring | Q35641798 | ||
| Androgen replacement after curative radical prostatectomy for prostate cancer in hypogonadal men. | Q35862931 | ||
| Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline | Q36486899 | ||
| Effect of testosterone administration to men with prostate cancer is unpredictable: a word of caution and suggestions for a registry | Q37868755 | ||
| Testosterone replacement therapy in the setting of prostate cancer treated with radiation | Q38042783 | ||
| Testosterone replacement in prostate cancer survivors with hypogonadal symptoms | Q39295915 | ||
| Prevalence of symptomatic androgen deficiency in men. | Q40183474 | ||
| The Response of Metastatic Adenocarcinoma of the Prostate to Exogenous Testosterone | Q40354735 | ||
| Studies on prostatic cancer: I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. 1941. | Q44018378 | ||
| Testosterone replacement therapy after primary treatment for prostate cancer | Q45219185 | ||
| Testosterone replacement therapy following radical prostatectomy | Q46126585 | ||
| Testosterone administration to men with testosterone deficiency syndrome after external beam radiotherapy for localized prostate cancer: preliminary observations | Q46451575 | ||
| Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer | Q46656860 | ||
| Intermittent androgen replacement for intense hypogonadism symptoms in castrated patients | Q46795416 | ||
| Response of men with advanced prostatic carcinoma to exogenous administration of testosterone. | Q53995805 | ||
| Testosterone replacement for hypogonadism after treatment of early prostate cancer with brachytherapy | Q79446008 | ||
| Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: the American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel report and recommendations for a standard in | Q79557156 | ||
| Testosterone replacement therapy following the diagnosis of prostate cancer: outcomes and utilization trends | Q87130247 | ||
| P433 | issue | 7 | |
| P921 | main subject | hypogonadism | Q938107 |
| testosterone | Q27863114 | ||
| P304 | page(s) | 536-541 | |
| P577 | publication date | 2015-04-01 | |
| P1433 | published in | American Journal of Health-System Pharmacy | Q15754037 |
| P1476 | title | Recurrence of prostate cancer in patients receiving testosterone supplementation for hypogonadism | |
| P478 | volume | 72 |
| Q48228328 | The prostate response to prolactin modulation in adult castrated rats subjected to testosterone replacement |
| Q42200949 | TrueNTH sexual recovery study protocol: a multi-institutional collaborative approach to developing and testing a web-based intervention for couples coping with the side-effects of prostate cancer treatment in a randomized controlled trial |
Search more.